BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
59 results:

  • 1. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat pancreatic cancer.
    Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
    Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Features of metabolism associated molecular patterns in pancreatic ductal adenocarcinoma.
    Chen J; Wang Y; Jiang H
    Cancer Gene Ther; 2023 Sep; 30(9):1296-1307. PubMed ID: 37414853
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Silencing of LAMC2 Reverses Epithelial Mesenchymal Transition and Inhibits Progression in pancreatic Ductal Adenocarcinoma via Inactivation of the NF-κB Signaling Pathway.
    Huang L; Han Y; Zhou Q; Sun Z; Yan J
    Crit Rev Eukaryot Gene Expr; 2023; 33(4):13-23. PubMed ID: 37183943
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma.
    Knappskog S; Grob T; Venizelos A; Amstutz U; Hjortland GO; Lothe IM; Kersten C; Hofsli E; Sundlöv A; Elvebakken H; Garresori H; Couvelard A; Svensson J; Sorbye H; Perren A
    JCO Precis Oncol; 2023 Feb; 7():e2200336. PubMed ID: 36753687
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
    de Andrés MP; Jackson RJ; Felipe I; Zagorac S; Pilarsky C; Schlitter AM; Martinez de Villareal J; Jang GH; Costello E; Gallinger S; Ghaneh P; Greenhalf W; Knösel T; Palmer DH; Ruemmele P; Weichert W; Buechler M; Hackert T; Neoptolemos JP; Notta F; Malats N; Martinelli P; Real FX
    Gut; 2023 Mar; 72(3):535-548. PubMed ID: 36109153
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases.
    Vanoli A; Grami O; Klersy C; Milanetto AC; Albarello L; Fassan M; Luchini C; Grillo F; Spaggiari P; Inzani F; Uccella S; Parente P; Nappo G; Mattiolo P; Milione M; Pietrabissa A; Cobianchi L; Schiavo Lena M; Partelli S; Di Sabatino A; Sempoux C; Capella C; Pasquali C; Doglioni C; Sessa F; Scarpa A; Rindi G; Paulli M; Zerbi A; Falconi M; Solcia E; La Rosa S
    Endocr Pathol; 2022 Jun; 33(2):274-288. PubMed ID: 35553369
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Molecular classification of pancreatic cancer].
    Tímár J
    Magy Onkol; 2021 Oct; 65(3):201-205. PubMed ID: 34614040
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured pancreatic cancer Cells.
    Morimoto D; Matsumura S; Bustos-Villalobos I; Sibal PA; Ichinose T; Naoe Y; Eissa IR; Abdelmoneim M; Mukoyama N; Miyajima N; Tanaka M; Kodera Y; Kasuya H
    Cells; 2021 Jun; 10(6):. PubMed ID: 34203706
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Collagen XI alpha 1 chain, a potential therapeutic target for cancer.
    Liu Z; Lai J; Jiang H; Ma C; Huang H
    FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]    [Full Text] [Related]  

  • 11. Pancreatoblastoma: A Case Report.
    Alhazmi T; Abduljabbar A; Alem M; Bahubaishi K
    Gulf J Oncolog; 2020 Sep; 1(34):87-90. PubMed ID: 33431369
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Spectrum of Uveal Metastasis in Korean Patients Based on Primary Tumor Origin.
    Kang HG; Kim M; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
    Ophthalmol Retina; 2021 Jun; 5(6):543-552. PubMed ID: 32942025
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent pancreatic cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
    Scarpa A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors.
    Kawasaki Y; Yang SJ; Choi GH; Han DH; Lee JH; Iino S; Sakoda M; Ueno S; Natsugoe S; Choi JS
    HPB (Oxford); 2019 Oct; 21(10):1393-1399. PubMed ID: 30922846
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.
    Gentiluomo M; Puchalt García P; Galeotti AA; Talar-Wojnarowska R; Tjaden C; Tavano F; Strobel O; Kupcinskas J; Neoptolemos J; Hegyi P; Costello E; Pezzilli R; Sperti C; Lawlor RT; Capurso G; Szentesi A; Soucek P; Vodicka P; Lovecek M; Hackert T; Cavestro GM; Milanetto AC; Canzian F; Campa D
    Carcinogenesis; 2019 Jun; 40(4):544-550. PubMed ID: 30629142
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
    Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
    J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.
    Harimoto N; Yoshizumi T; Inokuchi S; Itoh S; Adachi E; Ikeda Y; Uchiyama H; Utsunomiya T; Kajiyama K; Kimura K; Kishihara F; Sugimachi K; Tsujita E; Ninomiya M; Fukuzawa K; Maeda T; Shirabe K; Maehara Y
    Ann Surg Oncol; 2018 Oct; 25(11):3316-3323. PubMed ID: 30051372
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
    Arqueros C; Salazar J; Arranz MJ; Sebio A; Mora J; Sullivan I; Tobeña M; Martín-Richard M; Barnadas A; Baiget M; Páez D
    Med Oncol; 2017 Aug; 34(8):136. PubMed ID: 28687963
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gangliocytic Paraganglioma of the minor Papilla of the Duodenum.
    Matsubayashi H; Ishiwatari H; Matsui T; Fujie S; Uesaka K; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Ito T; Sasaki K; Ono H
    Intern Med; 2017; 56(9):1029-1035. PubMed ID: 28458307
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.